Alignment Healthcare Plunges 18% to 52-Week Low After Baird Conference Comments
ALHC is trading near its 52-week low of $10.35 (1.4% above the low).
Summary
Alignment Healthcare shares dropped nearly 18% to a new 52-week low after management's presentation at the Baird Global Healthcare Conference. The company did not revise its Q3 outlook, but investors reacted negatively to the commentary, marking the stock's biggest intraday decline in six weeks. This follows a 20% drop in July after Q2 revenue missed expectations, and the managed care sector has been under pressure, with CVS Health's recent cost concerns adding to the negative sentiment. The stock is now trading just above its 52-week low of $10.35, and the market is signaling continued concern about Medicare Advantage cost trends and growth prospects.
At the time of this announcement, ALHC was trading at $10.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $10.35 to $25.12. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.